Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis.
RHIZ'ART
1 other identifier
interventional
150
1 country
4
Brief Summary
The rhizarthrosis, or the degenerative osteoarthritis of the trapezo-metacarpal joint, is a frequent degenerative osteoarthritis. The treatment associates not pharmacological measures, such as resting relative of the joint, the orthosis of rest, glazing and pharmacological measures such analgesic, anti-inflammatory not steroidal per bones or premises, even infiltrations cortisone or by hyaluronic acid. No study has, for the moment, tested the interest of the combination of cortisone and hyaluronic acid in rhizarthrosis. In view of the current publications, we propose to carry out a study on two arms, with corticosteroids in reference arm; the experimental arm is the combination of hyaluronic acid and cortisone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started May 2018
Longer than P75 for phase_4
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2018
CompletedFirst Posted
Study publicly available on registry
February 13, 2018
CompletedStudy Start
First participant enrolled
May 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2021
CompletedResults Posted
Study results publicly available
September 29, 2025
CompletedDecember 2, 2025
November 1, 2025
3 years
February 6, 2018
October 30, 2023
November 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Analogical Visual Scale of Pain (VAS)
Analogical visual scale of pain (VAS) To 0 cm (no pain) form 10 cm (worst pain imaginable)
3 month post infiltration
Study Arms (2)
Infiltration of corticosteroids
ACTIVE COMPARATORInfiltration of corticosteroids and hyaluronic acid
EXPERIMENTALInterventions
infiltration of corticosteroids and hyaluronic acid
Eligibility Criteria
You may qualify if:
- Adults, ≥ 40 years
- Pain located at the root of the thumb (near the wrist) and awakened by direct pressure and movement
- Pain resistant to well-conducted medical treatment, with analgesics, NSAIDs, icing with pain (analog visual scale) ≥ 4 for more than 3 months
- Radiological findings (kapandji face + profile incidence) typical of rhizarthrosis, stage II or III of Eaton and Litter, with at least 2 of the following 5 radiological elements observed on the trapeziometacarpal joint:
- marginal osteophyte
- pinching of the joint space
- sclerosis of the subchondral space
- subchondral kyst
- absence of osteopenia
- Patient with the ability to understand the protocol and signed informed consent
- Patient receiving social security
You may not qualify if:
- Known allergy to any of the products (corticosteroids or hyaluronic acid) including its excipients (methyl parahydroxybenzoate, propyl parahydroxybenzoate, benzyl alcohol)
- Patients with symptomatic bilateral rhizarthrosis
- Scaphoid-trapezial arthrosis
- Local or general infection
- Severe coagulation disorders, ongoing anticoagulant therapy
- severe and / or uncontrolled hypertension
- Earlier local surgery
- Associated inflammatory rheumatism
- Tendinopathy of De Quervain, thumb to jump associated
- Infiltrations earlier than 6 months
- Diabetes imbalanced
- Live vaccines
- Severe water and / or sodium retention (hypernatremia), particularly in cases of heart failure, decompensated liver failure (edema and ascites failure)
- Pregnant or lactating women
- Immunocompromised or hemodialysis patients
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CH Cholet
Cholet, 49300, France
CHD Vendée
La Roche-sur-Yon, 85925, France
CH Le Mans
Le Mans, 72037, France
CHU Nantes
Nantes, 44000, France
Related Publications (2)
Cormier G, Le Goff B, Denis A, Varin S, Auzanneau L, Dimet J, Le Thuaut A. Corticosteroids injections versus corticosteroids with hyaluronic acid injections in rhizarthrosis: the randomised multicentre RHIZ'ART trial study protocol. BMJ Open. 2019 Jan 9;9(1):e022553. doi: 10.1136/bmjopen-2018-022553.
PMID: 30782680BACKGROUNDCormier G, Denis A, Leske C, Varin S, Dimet J, Planche L, Le Goff B. Improvement of rhizarthrosis pain management with the infiltration of hyaluronic acid and corticosteroids versus corticosteroids alone. Joint Bone Spine. 2025 Jul;92(4):105849. doi: 10.1016/j.jbspin.2025.105849. Epub 2025 Jan 30.
PMID: 39892589RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Grégoire CORMIER
- Organization
- Centre Hospitalier Departemental Vendée
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2018
First Posted
February 13, 2018
Study Start
May 11, 2018
Primary Completion
May 28, 2021
Study Completion
December 16, 2021
Last Updated
December 2, 2025
Results First Posted
September 29, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share